{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:31:24Z","timestamp":1792794684713,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31741079"],"award-info":[{"award-number":["31741079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2017J01621"],"award-info":[{"award-number":["2017J01621"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ymthe.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T12:06:26Z","timestamp":1612872386000},"page":"1758-1771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Junzhong","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanlu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Balderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.02.005_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.bjc.6603024","article-title":"Epigenetics as a mechanism driving polygenic clinical drug resistance","volume":"94","author":"Glasspool","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.005_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","article-title":"The epigenomics of cancer","volume":"128","author":"Jones","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.stem.2011.10.008","article-title":"Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients","volume":"9","author":"de Sousa E Melo","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2021.02.005_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.74.010904.153721","article-title":"Eukaryotic cytosine methyltransferases","volume":"74","author":"Goll","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2021.02.005_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature06146","article-title":"Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation","volume":"449","author":"Jia","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-4-32","article-title":"Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine","volume":"4","author":"Segura-Pacheco","year":"2006","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2021.02.005_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd2180","article-title":"Decitabine","volume":"5","author":"Gore","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.02.005_bib10","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/onc.2008.316","article-title":"Nucleoside analogs: molecular mechanisms signaling cell death","volume":"27","author":"Ewald","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2021.02.005_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd1698","article-title":"Azacitidine","volume":"4","author":"Issa","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2021.02.005_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35051606","article-title":"Inactivation of the apoptosis effector Apaf-1 in malignant melanoma","volume":"409","author":"Soengas","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cdp.2005.05.004","article-title":"Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells","volume":"29","author":"Qiu","year":"2005","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.ymthe.2021.02.005_bib14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/bjc.2011.161","article-title":"Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients","volume":"104","author":"Scartozzi","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.005_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00432-016-2157-9","article-title":"Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497","volume":"142","author":"Liu","year":"2016","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2017.01.004","article-title":"Clinical and biological effects of demethylating agents on solid tumours\u2014a systematic review","volume":"54","author":"Linnekamp","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ymthe.2021.02.005_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","article-title":"Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer","volume":"1","author":"Juergens","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2021.02.005_bib18","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2009-02-203547","article-title":"Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies","volume":"114","author":"Fandy","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2021.02.005_bib19","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1158\/0008-5472.CAN-11-3909","article-title":"Epigenetic resensitization to platinum in ovarian cancer","volume":"72","author":"Matei","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2021.02.005_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","article-title":"Gene body methylation can alter gene expression and is a therapeutic target in cancer","volume":"26","author":"Yang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI69736","article-title":"Harnessing the potential of epigenetic therapy to target solid tumors","volume":"124","author":"Ahuja","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.005_bib22","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1002\/cncr.25204","article-title":"A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer","volume":"116","author":"Fang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ymthe.2021.02.005_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI69737","article-title":"Predicting response to epigenetic therapy","volume":"124","author":"Treppendahl","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.005_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome\u2014biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2021.02.005_bib25","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.18632\/oncotarget.1542","article-title":"Alterations of immune response of non-small cell lung cancer with azacytidine","volume":"4","author":"Wrangle","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2021.02.005_bib26","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1038\/s41419-017-0024-5","article-title":"Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer","volume":"8","author":"Ramakrishnan","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2021.02.005_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.18632\/oncotarget.1782","article-title":"Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2021.02.005_bib28","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1073\/pnas.96.24.14007","article-title":"Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells","volume":"96","author":"Karpf","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.005_bib29","first-page":"371087","article-title":"Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I\/II report","volume":"2014","author":"Fan","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.ymthe.2021.02.005_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10637-014-0115-4","article-title":"A phase I study of decitabine with pegylated interferon \u03b1-2b in advanced melanoma: impact on DNA methylation and lymphocyte populations","volume":"32","author":"Plimack","year":"2014","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ymthe.2021.02.005_bib31","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1158\/1078-0432.CCR-06-0883","article-title":"Phase I trial of sequential low-dose 5-aza-2\u2032-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma","volume":"12","author":"Gollob","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2021.02.005_bib32","doi-asserted-by":"crossref","first-page":"e0139221","DOI":"10.1371\/journal.pone.0139221","article-title":"Treatment with 5-aza-2\u2032-deoxycytidine induces expression of NY-ESO-1 and facilitates cytotoxic T lymphocyte-mediated tumor cell killing","volume":"10","author":"Klar","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.02.005_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41467-017-02630-w","article-title":"DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2021.02.005_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.036","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"169","author":"Chiappinelli","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0198-8859(86)90304-6","article-title":"Effect of an inhibitor of DNA methylation on T\u00a0cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells","volume":"17","author":"Richardson","year":"1986","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib38","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.140.7.2197","article-title":"Hydralazine and procainamide inhibit T\u00a0cell DNA methylation and induce autoreactivity","volume":"140","author":"Cornacchia","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib39","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T\u00a0cells","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib40","doi-asserted-by":"crossref","first-page":"E10981","DOI":"10.1073\/pnas.1712514114","article-title":"Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden","volume":"114","author":"Stone","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.005_bib41","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","article-title":"Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model","volume":"3","author":"Wang","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2021.02.005_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-017-0358-y","article-title":"Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy","volume":"9","author":"Mazzone","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymthe.2021.02.005_bib43","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.02.005_bib44","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.02.005_bib45","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib46","doi-asserted-by":"crossref","first-page":"eaat8657","DOI":"10.1126\/science.aat8657","article-title":"cGAS in action: expanding roles in immunity and inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2021.02.005_bib47","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1621363114","article-title":"cGAS is essential for the antitumor effect of immune checkpoint blockade","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.005_bib48","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1172\/JCI123319","article-title":"PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer","volume":"129","author":"Chabanon","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2021.02.005_bib49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2021.02.005_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T\u00a0cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2021.02.005_bib51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.02.005_bib52","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","article-title":"STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity","volume":"112","author":"Demaria","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.005_bib53","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib54","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib55","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1128\/MCB.24.3.1270-1278.2004","article-title":"Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells","volume":"24","author":"Cheng","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib56","doi-asserted-by":"crossref","first-page":"e0120545","DOI":"10.1371\/journal.pone.0120545","article-title":"DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status","volume":"10","author":"Nakamura","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.02.005_bib57","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s10549-011-1477-3","article-title":"Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs","volume":"131","author":"Geutjes","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymthe.2021.02.005_bib58","first-page":"963","article-title":"Enhancement of gemcitabine sensitivity in pancreatic cancer by co-regulation of dCK and p8 expression","volume":"25","author":"Tang","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ymthe.2021.02.005_bib59","doi-asserted-by":"crossref","first-page":"e0168635","DOI":"10.1371\/journal.pone.0168635","article-title":"Methylation-sensitive melt curve analysis of the reprimo gene methylation in gastric cancer","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.02.005_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fendo.2016.00003","article-title":"The \u201cTSH receptor glo assay\u201d\u2014a high-throughput detection system for thyroid stimulation","volume":"7","author":"Latif","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymthe.2021.02.005_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10802","article-title":"DNA breaks and chromosome pulverization from errors in mitosis","volume":"482","author":"Crasta","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib62","doi-asserted-by":"crossref","first-page":"E4612","DOI":"10.1073\/pnas.1705499114","article-title":"cGAS is essential for cellular senescence","volume":"114","author":"Yang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.005_bib63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.005_bib64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-cancerbio-030518-055636","article-title":"Roles of the cGAS-STING pathway in cancer immunosurveillance and immunotherapy","volume":"3","author":"Yum","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","article-title":"A critical function for type I interferons in cancer immunoediting","volume":"6","author":"Dunn","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/0-387-24361-5_9","article-title":"Interferons in the treatment of solid tumors","volume":"126","author":"Moschos","year":"2005","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.ymthe.2021.02.005_bib67","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T\u00a0cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib68","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T\u00a0cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib69","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.4049\/jimmunol.1100926","article-title":"Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1\u03b2 production in human macrophages","volume":"187","author":"Novikov","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib70","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3390\/ijms18112456","article-title":"cGAS\/STING pathway in cancer: Jekyll and Hyde story of cancer immune response","volume":"18","author":"Bose","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2021.02.005_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.it.2017.07.013","article-title":"cGAS\u2013STING and cancer: dichotomous roles in tumor immunity and development","volume":"39","author":"Ng","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2021.02.005_bib72","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ccell.2018.03.027","article-title":"Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells","volume":"33","author":"Ahn","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib73","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.celrep.2019.09.065","article-title":"Cancer-cell-intrinsic cGAS expression mediates tumor immunogenicity","volume":"29","author":"Schadt","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.02.005_bib74","doi-asserted-by":"crossref","first-page":"e03187-19","DOI":"10.1128\/mBio.03187-19","article-title":"Connexin-dependent transfer of cGAMP to phagocytes modulates antiviral responses","volume":"11","author":"P\u00e9pin","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.ymthe.2021.02.005_bib75","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2021.02.005_bib76","doi-asserted-by":"crossref","first-page":"39858","DOI":"10.1038\/srep39858","article-title":"Decreased expression of STING predicts poor prognosis in patients with gastric cancer","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2021.02.005_bib77","doi-asserted-by":"crossref","first-page":"e0165681","DOI":"10.1371\/journal.pone.0165681","article-title":"Decreased expression of TMEM173 predicts poor prognosis in patients with hepatocellular carcinoma","volume":"11","author":"Bu","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2021.02.005_bib78","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.005_bib79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","article-title":"Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis","volume":"14","author":"Xia","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2021.02.005_bib80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00005-017-0481-7","article-title":"STING signaling in cancer cells: important or not?","volume":"66","author":"Sokolowska","year":"2018","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621000721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621000721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:59:35Z","timestamp":1761501575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621000721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1525001621000721"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.005","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}